Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Jan 7, 2008 at 5:21 PM EST

Isis: A Cholesterol/Lipid Diety (ISIS, GENZ)

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) and Genzyme Corp. (NASDAQ: GENZ) have entered into a major strategic alliance in which Genzyme…

Douglas A. McIntyre | Jan 4, 2008 at 3:22 PM EST

Biotechs and Related Hitting 52-Week Lows Too (BBH, AMGN, AMLN, ARNA, GERN, INGN, PGNX, SUPG)

Today has been a rough day with more 52-week lows than we can recall in quite some time. The biotechs…

Douglas A. McIntyre | Jan 2, 2008 at 1:43 PM EST

Becton Dickinson Finds A Friend In Staph Diagnostics (BDX)

Becton, Dickinson & Co. (NYSE: BDX) is seeing shares hitting new all-time highs as it has received clearance from the…

Douglas A. McIntyre | Dec 20, 2007 at 4:58 PM EST

Biotech Implosion: Genitope (GTOP)

Genitope Corp. (NASDAQ:GTOP) probably just made sure the workers’ kids won’t be getting much more than coal this year. Genitope…

Douglas A. McIntyre | Dec 18, 2007 at 9:06 AM EST

Medarex Gets A Small Handout From Amgen (MEDX, AMGN)

Medarex, Inc. (NASDAQ: MEDX) has announced that it will receive a milestone payment from Amgen (NASDAQ: AMGN). Unfortunately, Medarex said…

Douglas A. McIntyre | Dec 17, 2007 at 6:32 PM EST

Cramer’s Second Pick For Five Years Out: MedcoHealth (MHS)

On tonight’s MAD MONEY on CNBC, Jim Cramer said he wanted to review some picks that you might want to…

Douglas A. McIntyre | Dec 17, 2007 at 10:49 AM EST

10 Turnarounds That Haven’t Turned Around: Pfizer (PFE, MRK, BMY, JNJ)

Early this week we are running a list of stocks that have been in a turnaround plan, yet the stocks…

Douglas A. McIntyre | Dec 14, 2007 at 6:34 AM EST

FDA Sets New Stent Guidelines

For Boston Scientific (BSX) the news gets worse every day. The FDA says it will set up new guidelines for…

Douglas A. McIntyre | Dec 13, 2007 at 3:56 PM EST

Dendreon A Double Already? (DNDN)

If you read 24/WallSt.com’s "Ten Stocks That Could Double in 2008" from us, you saw that Dendreon (NASDAQ:DNDN) is on…

Douglas A. McIntyre | Dec 13, 2007 at 8:38 AM EST

Savient’s New Gout Treatment Hits Targets (SVNT)

Savient Pharmaceuticals Inc. (NASDAQ: SVNT) is seeing its shares surging in pre-market trading. The company showed statistically significant positive results…

Douglas A. McIntyre | Dec 12, 2007 at 4:44 PM EST

Biogen Loses BAIT SHOP Status, Officially & Again (BIIB, PFE)

Biogen-Iden (NASDAQ:BIIB) is seeing its shares pummeled in after-hours trading. The company didn’t have another biotech drug crisis though. Biogen…

Douglas A. McIntyre | Dec 11, 2007 at 5:30 PM EST

Biotech Short Interest NOV 2007 II (AMGN, BIIB, CELG, GENZ, GILD, IMCL, MEDX)

We’ve had a lot of biotech stocks see their shares get the wrath of news over recent days. Now that…

Douglas A. McIntyre | Dec 10, 2007 at 4:57 PM EST

Medarex Stubs Its Toe (MEDX, BMY, DNDN)

Medarex inc. (NASDAQ: MEDX) is seeing shares slapped in after-hours trading after the company is issuing disappointing news over the…

Douglas A. McIntyre | Dec 10, 2007 at 11:52 AM EST

Celgene Proves Riskier Than Imagined (CELG)

Celgene Corp. (NASDAQ:CELG) is seeing the price of its shares crushed today after trial results were shown on Sunday at…

Douglas A. McIntyre | Dec 7, 2007 at 12:12 PM EST

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

James Tobin, the CEO of Boston Scientific (NYSE:BSX) is likely to find himself in front of the shareholder firing squad…

1 … 359 360 361 362 363 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Isis: A Cholesterol/Lipid Diety (ISIS, GENZ)

Biotechs and Related Hitting 52-Week Lows Too (BBH, AMGN, AMLN, ARNA, GERN, INGN, PGNX, SUPG)

Becton Dickinson Finds A Friend In Staph Diagnostics (BDX)

Biotech Implosion: Genitope (GTOP)

Medarex Gets A Small Handout From Amgen (MEDX, AMGN)

Cramer’s Second Pick For Five Years Out: MedcoHealth (MHS)

10 Turnarounds That Haven’t Turned Around: Pfizer (PFE, MRK, BMY, JNJ)

FDA Sets New Stent Guidelines

Dendreon A Double Already? (DNDN)

Savient’s New Gout Treatment Hits Targets (SVNT)

Biogen Loses BAIT SHOP Status, Officially & Again (BIIB, PFE)

Biotech Short Interest NOV 2007 II (AMGN, BIIB, CELG, GENZ, GILD, IMCL, MEDX)

Medarex Stubs Its Toe (MEDX, BMY, DNDN)

Celgene Proves Riskier Than Imagined (CELG)

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Health and Healthcare Articles

All Health and Healthcare Articles

Isis: A Cholesterol/Lipid Diety (ISIS, GENZ)

Biotechs and Related Hitting 52-Week Lows Too (BBH, AMGN, AMLN, ARNA, GERN, INGN, PGNX, SUPG)

Becton Dickinson Finds A Friend In Staph Diagnostics (BDX)

Biotech Implosion: Genitope (GTOP)

Medarex Gets A Small Handout From Amgen (MEDX, AMGN)

Cramer’s Second Pick For Five Years Out: MedcoHealth (MHS)

10 Turnarounds That Haven’t Turned Around: Pfizer (PFE, MRK, BMY, JNJ)

FDA Sets New Stent Guidelines

Dendreon A Double Already? (DNDN)

Savient’s New Gout Treatment Hits Targets (SVNT)

Biogen Loses BAIT SHOP Status, Officially & Again (BIIB, PFE)

Biotech Short Interest NOV 2007 II (AMGN, BIIB, CELG, GENZ, GILD, IMCL, MEDX)

Medarex Stubs Its Toe (MEDX, BMY, DNDN)

Celgene Proves Riskier Than Imagined (CELG)

10 CEO’s That Need To Leave in 2008: James Tobin of Boston Scientific (BSX, BIIB, JNJ, ABT)

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%